Quincy Bioscience Holding Company

Last Updated:
Federal Trade Commission and the People of the State of New York, by Eric T. Schneiderman, Attorney General of the State of New York, Plaintiffs, v. Quincy Bioscience Holding Company, Inc., a corporation; Quincy Bioscience, LLC, a limited liability company; Prevagen, Inc., a corporation doing business as Sugar River Supplements; Quincy Bioscience Manufacturing, LLC, a limited liability company; Mark Underwood, individually and as an officer of Quincy Bioscience Holding Company, Inc., Quincy Bioscience, LLC, and Prevagen, Inc.; and Michael Beaman, individually and as an officer of Quincy Bioscience Holding Company, Inc., Quincy Bioscience, LLC, and Prevagen, Inc., Defendants.
FTC Matter/File Number:

152 3206

Civil Action Number:

1:17-cv-00124

Enforcement Type:

Federal Injunctions

Federal Court:
Southern District of New York

Case Summary

The FTC and New York State AG have charged the marketers of the dietary supplement Prevagen with making false and unsubstantiated claims that the product improves memory, provides cognitive benefits, and is “clinically shown” to work.